US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist

85.070
+1.450+1.73%

Close Apr 23 16:00 ET

85.070
0.0000.00%

Post 16:04 ET

4.32BMarket Cap34.58P/E (TTM)

Haemonetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Dec 30, 2023

(Q2)Sep 30, 2023

(Q1)Jul 1, 2023

(FY)Apr 1, 2023

(Q4)Apr 1, 2023

(Q3)Dec 31, 2022

(Q2)Oct 1, 2022

(Q1)Jul 2, 2022

(FY)Apr 2, 2022

(Q4)Apr 2, 2022

Total revenue

10.14%336.25M

6.96%318.18M

19.08%311.33M

17.67%1.17B

14.87%304.42M

305.3M

24.01%297.49M

14.41%261.46M

993.2M

265M

Operating revenue

10.14%336.25M

6.96%318.18M

19.08%311.33M

17.67%1.17B

14.87%304.42M

--305.3M

24.01%297.49M

14.41%261.46M

--993.2M

--265M

Cost of revenue

8.04%158.38M

5.78%147.67M

20.87%144.07M

13.51%553.56M

15.13%148.17M

146.59M

18.96%139.61M

-1.04%119.2M

487.69M

128.69M

Gross profit

12.07%177.87M

8.00%170.51M

17.57%167.27M

21.68%615.1M

14.63%156.25M

158.71M

28.84%157.88M

31.62%142.26M

505.5M

136.31M

Operating expense

14.26%131.89M

12.27%124.79M

1.89%113.61M

5.78%459.45M

3.64%121.38M

115.43M

13.38%111.15M

-4.13%111.5M

434.36M

117.11M

Selling and administrative expenses

18.01%111.71M

13.99%104.9M

1.36%93.49M

10.74%376.68M

5.78%97.76M

--94.66M

21.45%92.03M

1.11%92.23M

--340.14M

--92.42M

Research and development costs

4.54%13.27M

16.24%12.67M

16.02%12.65M

7.12%50.13M

18.43%15.64M

--12.69M

0.40%10.9M

-14.16%10.9M

--46.8M

--13.21M

Depreciation amortization depletion

-14.45%6.91M

-12.15%7.22M

-10.68%7.47M

-31.16%32.64M

-30.56%7.97M

--8.08M

-27.89%8.22M

-32.41%8.37M

--47.41M

--11.48M

-Depreciation and amortization

-14.45%6.91M

-12.15%7.22M

-10.68%7.47M

-31.16%32.64M

-30.56%7.97M

--8.08M

-27.89%8.22M

-32.41%8.37M

--47.41M

--11.48M

Operating profit

6.24%45.98M

-2.16%45.72M

74.40%53.66M

118.77%155.65M

81.64%34.87M

43.28M

90.67%46.73M

474.61%30.77M

71.15M

19.2M

Net non-operating interest income expense

-84.74%-1.95M

56.44%-2.47M

60.76%-2.07M

14.55%-14.63M

32.10%-2.63M

-1.06M

-23.65%-5.67M

-19.90%-5.27M

-17.12M

-3.87M

Non-operating interest expense

84.74%1.95M

-56.44%2.47M

-60.76%2.07M

-14.55%14.63M

-32.10%2.63M

--1.06M

23.65%5.67M

19.90%5.27M

--17.12M

--3.87M

Other net income (expense)

-10.42M

-96.02%382K

9.6M

Special income (charges)

--0

---10.42M

----

-96.02%382K

--382K

--0

----

--9.6M

--0

-Less:Impairment of capital assets

--0

--10.42M

----

--0

----

-Gain on sale of business

----

-96.02%382K

----

--9.6M

--0

Income before tax

4.27%44.03M

-20.04%32.83M

102.36%51.59M

122.23%141.4M

112.87%32.63M

42.22M

106.10%41.06M

947.54%25.49M

63.63M

15.33M

Income tax

37.80%12.79M

0.79%7.92M

87.79%10.55M

28.38%26M

-41.94%3.24M

9.28M

55.19%7.86M

288.45%5.62M

20.25M

5.59M

Net income

-5.17%31.24M

-24.97%24.91M

106.48%41.04M

166.05%115.4M

201.64%29.38M

32.94M

123.46%33.2M

546.27%19.88M

43.38M

9.74M

Net income continuous Operations

-5.17%31.24M

-24.97%24.91M

106.48%41.04M

166.05%115.4M

201.64%29.38M

--32.94M

123.46%33.2M

546.27%19.88M

--43.38M

--9.74M

Minority interest income

Net income attributable to the parent company

-5.17%31.24M

-24.97%24.91M

106.48%41.04M

166.05%115.4M

201.64%29.38M

32.94M

123.46%33.2M

546.27%19.88M

43.38M

9.74M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-5.17%31.24M

-24.97%24.91M

106.48%41.04M

166.05%115.4M

201.64%29.38M

32.94M

123.46%33.2M

546.27%19.88M

43.38M

9.74M

Basic earnings per share

-4.62%0.62

-24.62%0.49

107.69%0.81

167.06%2.27

205.65%0.5825

0.65

124.14%0.65

533.33%0.39

0.85

0.1906

Diluted earnings per share

-4.69%0.61

-25.00%0.48

110.53%0.8

166.67%2.24

200.00%0.57

0.64

120.69%0.64

522.22%0.38

0.84

0.19

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Dec 30, 2023	(Q2)Sep 30, 2023	(Q1)Jul 1, 2023	(FY)Apr 1, 2023	(Q4)Apr 1, 2023	(Q3)Dec 31, 2022	(Q2)Oct 1, 2022	(Q1)Jul 2, 2022	(FY)Apr 2, 2022	(Q4)Apr 2, 2022
Total revenue	10.14%336.25M	6.96%318.18M	19.08%311.33M	17.67%1.17B	14.87%304.42M	305.3M	24.01%297.49M	14.41%261.46M	993.2M	265M
Operating revenue	10.14%336.25M	6.96%318.18M	19.08%311.33M	17.67%1.17B	14.87%304.42M	--305.3M	24.01%297.49M	14.41%261.46M	--993.2M	--265M
Cost of revenue	8.04%158.38M	5.78%147.67M	20.87%144.07M	13.51%553.56M	15.13%148.17M	146.59M	18.96%139.61M	-1.04%119.2M	487.69M	128.69M
Gross profit	12.07%177.87M	8.00%170.51M	17.57%167.27M	21.68%615.1M	14.63%156.25M	158.71M	28.84%157.88M	31.62%142.26M	505.5M	136.31M
Operating expense	14.26%131.89M	12.27%124.79M	1.89%113.61M	5.78%459.45M	3.64%121.38M	115.43M	13.38%111.15M	-4.13%111.5M	434.36M	117.11M
Selling and administrative expenses	18.01%111.71M	13.99%104.9M	1.36%93.49M	10.74%376.68M	5.78%97.76M	--94.66M	21.45%92.03M	1.11%92.23M	--340.14M	--92.42M
Research and development costs	4.54%13.27M	16.24%12.67M	16.02%12.65M	7.12%50.13M	18.43%15.64M	--12.69M	0.40%10.9M	-14.16%10.9M	--46.8M	--13.21M
Depreciation amortization depletion	-14.45%6.91M	-12.15%7.22M	-10.68%7.47M	-31.16%32.64M	-30.56%7.97M	--8.08M	-27.89%8.22M	-32.41%8.37M	--47.41M	--11.48M
-Depreciation and amortization	-14.45%6.91M	-12.15%7.22M	-10.68%7.47M	-31.16%32.64M	-30.56%7.97M	--8.08M	-27.89%8.22M	-32.41%8.37M	--47.41M	--11.48M
Operating profit	6.24%45.98M	-2.16%45.72M	74.40%53.66M	118.77%155.65M	81.64%34.87M	43.28M	90.67%46.73M	474.61%30.77M	71.15M	19.2M
Net non-operating interest income expense	-84.74%-1.95M	56.44%-2.47M	60.76%-2.07M	14.55%-14.63M	32.10%-2.63M	-1.06M	-23.65%-5.67M	-19.90%-5.27M	-17.12M	-3.87M
Non-operating interest expense	84.74%1.95M	-56.44%2.47M	-60.76%2.07M	-14.55%14.63M	-32.10%2.63M	--1.06M	23.65%5.67M	19.90%5.27M	--17.12M	--3.87M
Other net income (expense)		-10.42M		-96.02%382K					9.6M	0
Special income (charges)	--0	---10.42M	----	-96.02%382K	--382K	--0	--0	----	--9.6M	--0
-Less:Impairment of capital assets	--0	--10.42M	----	----	----	--0	--0	----	----	----
-Gain on sale of business	----	----	----	-96.02%382K	----	----	----	----	--9.6M	--0
Income before tax	4.27%44.03M	-20.04%32.83M	102.36%51.59M	122.23%141.4M	112.87%32.63M	42.22M	106.10%41.06M	947.54%25.49M	63.63M	15.33M
Income tax	37.80%12.79M	0.79%7.92M	87.79%10.55M	28.38%26M	-41.94%3.24M	9.28M	55.19%7.86M	288.45%5.62M	20.25M	5.59M
Net income	-5.17%31.24M	-24.97%24.91M	106.48%41.04M	166.05%115.4M	201.64%29.38M	32.94M	123.46%33.2M	546.27%19.88M	43.38M	9.74M
Net income continuous Operations	-5.17%31.24M	-24.97%24.91M	106.48%41.04M	166.05%115.4M	201.64%29.38M	--32.94M	123.46%33.2M	546.27%19.88M	--43.38M	--9.74M
Minority interest income
Net income attributable to the parent company	-5.17%31.24M	-24.97%24.91M	106.48%41.04M	166.05%115.4M	201.64%29.38M	32.94M	123.46%33.2M	546.27%19.88M	43.38M	9.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-5.17%31.24M	-24.97%24.91M	106.48%41.04M	166.05%115.4M	201.64%29.38M	32.94M	123.46%33.2M	546.27%19.88M	43.38M	9.74M
Basic earnings per share	-4.62%0.62	-24.62%0.49	107.69%0.81	167.06%2.27	205.65%0.5825	0.65	124.14%0.65	533.33%0.39	0.85	0.1906
Diluted earnings per share	-4.69%0.61	-25.00%0.48	110.53%0.8	166.67%2.24	200.00%0.57	0.64	120.69%0.64	522.22%0.38	0.84	0.19
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall